• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Science . Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans

tetano

Editor, Senior Moderator
Science


. 2020 Aug 4;eabd3871.
doi: 10.1126/science.abd3871. Online ahead of print.
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans


Jose Mateus[SUP] 1 [/SUP], Alba Grifoni[SUP] 1 [/SUP], Alison Tarke[SUP] 1 [/SUP], John Sidney[SUP] 1 [/SUP], Sydney I Ramirez[SUP] 1 2 [/SUP], Jennifer M Dan[SUP] 1 2 [/SUP], Zoe C Burger[SUP] 2 [/SUP], Stephen A Rawlings[SUP] 2 [/SUP], Davey M Smith[SUP] 2 [/SUP], Elizabeth Phillips[SUP] 3 [/SUP], Simon Mallal[SUP] 3 [/SUP], Marshall Lammers[SUP] 1 [/SUP], Paul Rubiro[SUP] 1 [/SUP], Lorenzo Quiambao[SUP] 1 [/SUP], Aaron Sutherland[SUP] 1 [/SUP], Esther Dawen Yu[SUP] 1 [/SUP], Ricardo da Silva Antunes[SUP] 1 [/SUP], Jason Greenbaum[SUP] 1 [/SUP], April Frazier[SUP] 1 [/SUP], Alena J Markmann[SUP] 4 [/SUP], Lakshmanane Premkumar[SUP] 5 [/SUP], Aravinda de Silva[SUP] 5 [/SUP], Bjoern Peters[SUP] 1 2 [/SUP], Shane Crotty[SUP] 1 2 [/SUP], Alessandro Sette[SUP] #[/SUP][SUP] 6 2 [/SUP], Daniela Weiskopf[SUP] #[/SUP][SUP] 6 [/SUP]



Affiliations

Abstract

Many unknowns exist about human immune responses to the SARS-CoV-2 virus. SARS-CoV-2 reactive CD4[SUP]+[/SUP] T cells have been reported in unexposed individuals, suggesting pre-existing cross-reactive T cell memory in 20-50% of people. However, the source of those T cells has been speculative. Using human blood samples derived before the SARS-CoV-2 virus was discovered in 2019, we mapped 142 T cell epitopes across the SARS-CoV-2 genome to facilitate precise interrogation of the SARS-CoV-2-specific CD4[SUP]+[/SUP] T cell repertoire. We demonstrate a range of pre-existing memory CD4[SUP]+[/SUP] T cells that are cross-reactive with comparable affinity to SARS-CoV-2 and the common cold coronaviruses HCoV-OC43, HCoV-229E, HCoV-NL63, or HCoV-HKU1. Thus, variegated T cell memory to coronaviruses that cause the common cold may underlie at least some of the extensive heterogeneity observed in COVID-19 disease.
 
Back
Top Bottom